Nahdi Medical Company
4164
Kedudukan dalam Saham
#4849
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Harga Saham
$23.41
Modal Pasaran
$3.04B
Perubahan (1 hari)
-0.06%
Perubahan (1 tahun)
-26.77%
Negara
SA
Perdagangan Nahdi Medical Company (4164)
Kategori
Healthcare
Hasil untuk Nahdi Medical Company (4164)
Hasil pada Jun 2026 TTM: $2.80B
Menurut laporan kewangan terkini daripada Nahdi Medical Company, hasil semasa syarikat (TTM) ialah $2.80B. Pada tahun 2023, syarikat memperoleh hasil sebanyak $2.32B peningkatan berbanding hasil pada tahun 2022 iaitu $2.29B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Nahdi Medical Company dari 2017 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $2.80B | 11.55% |
| 2024 | $2.51B | 8.21% |
| 2023 | $2.32B | 1.37% |
| 2022 | $2.29B | 6.69% |
| 2021 | $2.15B | -6.73% |
| 2020 | $2.30B | 10.44% |
| 2019 | $2.09B | 6.47% |
| 2018 | $1.96B | 4.11% |
| 2017 | $1.88B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $2.54B | -9.59% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $830.81M | -70.38% |
US
|
